COVID Vaccines Linked To A 145-Times Increase In Reports Of Menstrual AbnormalitiesA new study on VAERS data from Thorp et al found COVID-19 vaccines VS flu vaccines were associated with:
- 145-times increase in reports of menstrual abnormalities.
- 6-times increase in reports of miscarriages.
- 6-times increase in reports of fetal cardiac disorders.
Also, the data indicated COVID-19 did not influence the baseline rate of US fetal death, (~5.8 per 1,000 births/2017-2020) but after the COVID-19 vaccine rollout, there was a nearly 400% increase in rate of stillbirths which skyrocketed to 29.3/1,000 between Jul 2021-Aug 2022.
It should be noted, all data from the image below was from Whistleblower Michelle Gershon.
mRNA COVID Vaccine Induced IgG4 Antibody Class Shift May Reduce The Body’s Ability To Clear Future InfectionsA new study by Irrgang et al identified a large spike protein specific IgG4 antibody class switch (from 0.04%-19.27%) after 3 mRNA vaccine doses which implicated a substantial decrease in the immune systems capacity to clear subsequent SARS-CoV-2 infections, and spike protein. That evidenced by the reduced ability of spike-specific antibodies to mediate antibody-dependent phagocytosis and complement deposition.
Essentially, phagocytosis, and the complement system are used by the body to rid itself of pathogens, and much more. Both of the previously mentioned are implicated in a plethora of immune mediated responses, not simply viral clearance.
Just so it is clear, serum concentrations of IgG4 antibodies above 1-3% have historically been associated with pathology AKA disease. That said, the worry is that frequent boosting may truncate, or reduce, the immune systems ability to handle future SARS-CoV-2 infections, or clear viral antigens (viral parts i.e. spike protein) from the body.
New CDC Data Indicated Omicron BA5 Nearly ExtinctLatest CDC Nowcast data indicated that as of 12/24/22 Omicron BA.5 was nearly extinct making up only 6.9% of cases. Moreover, dominant sublineages BQ.1.1, and BQ.1 make up 35.7%, and 27.4% of cases respectively.